Tali Voloshin Preclinical Research Department Novocure Ltd., Haifa, Israel Biography Publications Institution JoVE Articles Tali Voloshin has not added a biography. If you are Tali Voloshin and would like to personalize this page please email our Author Liaison for assistance. Publications Alternating Electric Fields (TTFields) in Combination with Paclitaxel Are Therapeutically Effective Against Ovarian Cancer Cells in Vitro and in Vivo International Journal of Cancer. Dec, 2016 | Pubmed ID: 27561100 Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells Scientific Reports. Dec, 2015 | Pubmed ID: 26658786 Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis Molecular Cancer Therapeutics. Jun, 2015 | Pubmed ID: 25887886 Recruitment of Oligoclonal Viral-Specific T Cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion Molecules Molecular Cancer Therapeutics. Jun, 2015 | Pubmed ID: 25852061 Alternating Electric Fields (tumor-treating Fields Therapy) Can Improve Chemotherapy Treatment Efficacy in Non-small Cell Lung Cancer Both in Vitro and in Vivo Seminars in Oncology. Oct, 2014 | Pubmed ID: 25213867 Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy Neoplasia (New York, N.Y.). Jun, 2014 | Pubmed ID: 24957319 Small but Mighty: Microparticles As Mediators of Tumor Progression Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. Aug, 2014 | Pubmed ID: 24705797 Tumor-derived Microparticles Induce Bone Marrow-derived Cell Mobilization and Tumor Homing: a Process Regulated by Osteopontin International Journal of Cancer. Jul, 2014 | Pubmed ID: 24347266 Differential Therapeutic Effects of Anti-VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing Molecular Cancer Therapeutics. Jan, 2014 | Pubmed ID: 24150126 Lysyl Oxidase-like-2 Promotes Tumour Angiogenesis and is a Potential Therapeutic Target in Angiogenic Tumours Carcinogenesis. Oct, 2013 | Pubmed ID: 23828904 The Host Immunological Response to Cancer Therapy: An Emerging Concept in Tumor Biology Experimental Cell Research. Jul, 2013 | Pubmed ID: 23518388 Tumor-initiating Cells of Various Tumor Types Exhibit Differential Angiogenic Properties and React Differently to Antiangiogenic Drugs Stem Cells (Dayton, Ohio). Sep, 2012 | Pubmed ID: 22782858 Host Response to Short-term, Single-agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice Cancer Research. Nov, 2011 | Pubmed ID: 21978934 G-CSF Supplementation with Chemotherapy Can Promote Revascularization and Subsequent Tumor Regrowth: Prevention by a CXCR4 Antagonist Blood. Sep, 2011 | Pubmed ID: 21685373 The Angiogenic Profile of Colorectal Cancer Patients Following Open or Laparoscopic Colectomy Cancer Biology & Therapy. Oct, 2010 | Pubmed ID: 20814248 Bestemme Optimal Hemmende Frekvens for kreftceller Bruke Tumor Behandling av Fields (TTFields) Yaara Porat1, Moshe Giladi1, Rosa S. Schneiderman1, Roni Blat1, Anna Shteingauz1, Einav Zeevi1, Mijal Munster1, Tali Voloshin1, Noa Kaynan1, Orna Tal1, Eilon D. Kirson2, Uri Weinberg3, Yoram Palti2 1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland JoVE 55820 Cancer Research
Bestemme Optimal Hemmende Frekvens for kreftceller Bruke Tumor Behandling av Fields (TTFields) Yaara Porat1, Moshe Giladi1, Rosa S. Schneiderman1, Roni Blat1, Anna Shteingauz1, Einav Zeevi1, Mijal Munster1, Tali Voloshin1, Noa Kaynan1, Orna Tal1, Eilon D. Kirson2, Uri Weinberg3, Yoram Palti2 1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland JoVE 55820 Cancer Research
